How B-cells and androgens contribute to the development of PCOS

GSK’s PD-1 an­ti­body Jem­per­li has hit the bench­mark in a late-stage en­dome­tri­al can­cer test, paving the way for a po­ten­tial la­bel ex­pan­sion be­yond its cur­rent

John­son & John­son is wind­ing down its phar­ma di­vi­sion’s car­dio­vas­cu­lar and meta­bol­ic unit, End­points News has learned. The de­ci­sion pri­mar­i­ly im­pacts the sales, mar­ket­ing and